Scleroderma Lung Study II—clarity or obfuscation?
نویسندگان
چکیده
منابع مشابه
Fibrocytes in Scleroderma Lung Fibrosis
Systemic sclerosis (SSc) or “Scleroderma” is a disease characterized by cutaneous and visceral fibrosis that affects both the skin and internal organs. The worldwide prevalence ranges from 50-300 cases per million (Chifflot et al., 2008) and much of the morbidity in this population results from pulmonary complications. In fact, nearly 70% of scleroderma patients show some form of lung disease. ...
متن کاملInterstitial lung disease in scleroderma
Pulmonary involvement is quite frequent in the development of progressive systemic sclerosis (PSS), a disease that affects the skin and internal organs and may present in various forms, especially as interstitial lung disease (ILD) or pulmonary hypertension (PH).(1) The incidence of pulmonary involvement varies depending on the population and on the methodology used for the diagnosis, reaching ...
متن کاملCyclophosphamide for scleroderma lung disease.
2707 age readers to recommend topics of interest and have established a separate e-mail address ([email protected]) for readers to submit their ideas or comments regarding the new series. Clinically significant interstitial lung disease affects patients with systemic sclerosis (scleroderma) and is a cause of morbidity and mortality in approximately 40 percent of these patients. 1 Ma...
متن کاملScleroderma-related interstitial lung disease
Scleroderma-related interstitial lung disease (SSc-ILD) is a pulmonary fibrosing disorder characterized by systemic inflammation and progressive scarring of the lungs that leads to respiratory failure. Although certain immunosuppressive therapies may slow disease progression, current treatment strategies are not curative; consequently, SSc-ILD continues to be a major cause of morbidity and mort...
متن کاملScleroderma and Lung CHAPTER 15
Scleroderma is a chronic systemic disease of unknown cause, affecting around 15 persons in one million inhabitants in all parts of the world, but most frequently women between 40–60 years of age. Until recently, scleroderma was considered to be a disease with gloomy prognosis and no cure. The general attitude has changed during last decades due to successful treatment of scleroderma renal crisi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Lancet Respiratory Medicine
سال: 2016
ISSN: 2213-2600
DOI: 10.1016/s2213-2600(16)30191-6